Printer Friendly

Browse Raloxifene topic


1-70 out of 70 article(s)
Title Author Type Date Words
A Simple Colorimetric Method for the Determination of Raloxifene Hydrochloride in Pharmaceuticals Using Modified Romini's Reagent. Reddy, Kovvuru Praneeth Kumar; Prathap, Kale Muni Sai; Sharma, Hemraj; Kumar, Kondareddy Vinod Dec 31, 2019 2493
Tamoxifen, Raloxifene Linked to Improvements in MD in Mice; Improvements include increase in grip force production, extended running time and distance. Mar 20, 2018 221
Decompensation in a 51-year-old woman with schizophrenia. Riddle, Megan; Buchholz, Jonathan Report Mar 1, 2018 3452
Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation. Gonzalez-Rodriguez, Elena; Stoll, Delphine; Lamy, Olivier Jan 1, 2018 2468
Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat. Posa, Aniko; Szabo, Renata; Kupai, Krisztina; Berko, Aniko Magyarine; Veszelka, Medea; Szucs, Gergo; Report Jan 1, 2017 6278
Dr Reddy's Laboratories unveils Raloxifene HCl Tablets, USP in the US market. Nov 14, 2016 141
Dr Reddy's Laboratories unveils Raloxifene HCl Tablets, USP in the US market. Nov 14, 2016 145
Report Published: "China Raloxifene Market, 2010-2019". Jul 29, 2015 385
Alendronate versus raloxifene for postmenopausal women: a meta-analysis of seven head-to-head randomized controlled trials. Lin, Tiao; Yan, Shi-Gui; Cai, Xun-Zi; Ying, Zhi-Min; Yuan, Fu-Zhen; Zuo, Xi Report Jan 1, 2014 12092
Investigating effect of Raloxifene on the factors of blood urea nitrogen, uric acid and creatinine in female rats. Zahra, Ebadi; Hossein, Kargar Jahromi; Fakhrossadat, Ghorishi; Ali, Zahedi; Zahra, Khodaparast; Sara Report Dec 1, 2013 2232
Raloxifene eyed as added schizophrenia therapy. Smith, Jennie Jul 1, 2012 1423
Relation of BMI and postmenopausal duration with antioxidant and anti-inflammatory effects of raloxifene treatment in women with osteoporosis: a preliminary report/Osteoporozlu kadinlarda raloksifen tedavisinin antioksidan ve antiinflamatuvar etkilerininin VKI ve menopoz suresi ile iliskisi. Akcay, Yasemin; Eyigor, Sibel; Ilanbey, Bilal; Karadeniz, Muammer; Kirazli, Yesim; Sozmen, Eser Report Mar 1, 2012 5650
Raloxifene did not increase lupus activity in study. Mahoney, Diana Oct 1, 2011 564
Tamoxifen and raloxifene hold up as breast cancer prevention. Wachter, Kerri May 15, 2010 883
The case for chemoprevention as a tool to avert breast cancer: women at high risk of invasive breast cancer can elect chemoprevention with tamoxifen or raloxifene. An aromatase inhibitor may one day be an option. Goldstein, Steven R. Report Jul 1, 2009 5022
Zoledronic acid tops raloxifene for bone loss. Sullivan, Michele G. Report May 15, 2009 522
Framingham score IDs risk with raloxifene. McNamara, Damian Brief article Nov 1, 2008 241
While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene also appears to lower the odds of developing endometrial cancer, researchers report in the September 1st issue of the Journal of Clinical Oncology. Brief article Sep 29, 2008 220
Osteoporosis: recent data refine our understanding of how to use key drugs, particularly bisphosphonates, zoledronic acid, recombinant PTH, and raloxifene. Goldstein, Steven R. Nov 1, 2007 311
Second SERM gets approved to lower breast cancer risk: warning added on stroke, embolism risks. Mechcatie, Elizabeth Oct 1, 2007 846
Raloxifene wins approval for curbing breast Ca risk. Mechcatie, Elizabeth Oct 1, 2007 839
Eli Lilly & Co. (Indianapolis IN), the maker of the osteoporosis medicine Evista, won approval for the drug's use to reduce risks of invasive breast cancer in certain women. Brief article Sep 17, 2007 192
Sore spot. Brief article Sep 1, 2007 249
Panel backs osteoporosis drug for reducing breast ca risk. Bullock, Lorinda Sep 1, 2007 495
Panel okays drug to lower breast ca risk. Bullock, Lorinda Aug 15, 2007 630
Breast cancer chemoprevention is underrated. Jancin, Bruce Jan 15, 2007 617
Raloxifene (Evista) therapy for the heart--good news, bad news. Brief article Sep 1, 2006 144
Raloxifene prevents breast cancer as well as tamoxifen. Brief article Jun 1, 2006 201
Raloxifene matches tamoxifen for breast cancer: the star trial measured prevention of invasive breast cancer in women at high risk for the disease. Finn, Robert May 15, 2006 769
Raloxifene works for prevention of invasive breast cancer risk reduction comparable to tamoxifen. Finn, Robert Clinical report May 15, 2006 768
Raloxifene halves invasive breast cancer risk: the selective estrogen receptor modulator was associated with same risk reduction as tamoxifen. Finn, Robert Clinical report May 15, 2006 770
Two drugs are equal in preventing breast cancer. Brief article May 6, 2006 211
Raloxifene tied to 50% cut in endometrial ca risk. MacNeil, Jane Salodof Jul 15, 2005 332
Extended use of raloxifene cuts breast cancer risk: combined trials gather 8 years of data. Jancin, Bruce Feb 15, 2005 655
Extended raloxifene continues to protect some. Jancin, Bruce Feb 15, 2005 682
Raloxifene and PTH may have synergistic effect on BMD. Kirn, Timothy F. Feb 1, 2005 500
Raloxifene, PTH are good osteoporosis combo: together, the two drugs could potentially maximize the formation and minimize the resorption of bone. Kirn, Timothy F. Feb 1, 2005 526
Raloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy. Johnell, Olof; Cauley, Jane A.; Kulkarni, Pandurang M.; Wong, Mayme; Stock, John L. Oct 1, 2004 4507
Triglycerides do not alter raloxifene's lipid effects. Jancin, Bruce Sep 1, 2004 372
Raloxifene's lipid benefits extend to women with high triglycerides. Jancin, Bruce Aug 15, 2004 391
Roundup of cognition studies yields mixed bag: tamoxifen, serms, soy. Splete, Heidi May 15, 2004 771
Raloxifene appears to hold benefits for older women: patients randomized to the drug demonstrated a significantly decreased probability of impairment on tests of verbal recall. Splete, Heidi May 1, 2004 853
Lipid profiles of nonwhite women benefit from raloxifene: posthoc analysis. Sullivan, Michele G. Feb 15, 2004 355
Raloxifene for 4 years is not linked to gallbladder disease: posthoc analysis. Sullivan, Michele G. Brief Article Nov 1, 2003 201
Head-to-head comparison of osteoporosis drugs: alendronate vs. raloxifene. Johnson, Kate Product/Service Evaluation Aug 1, 2003 452
'Hang in there' despite BMD loss during therapy: may rebound in second year. (Clinical Rounds). Mulcahy, Nicholas Apr 1, 2003 364
Raloxifene being tested for premenopausal chemoprevention. (Well Tolerated So Far in Open-Label Trial). Mar 15, 2003 416
Breast ca prevention could be next for raloxifene. (Phase II Data). Jancin, Bruce Mar 15, 2003 367
BMD may rebound in second year of therapy. (In Osteoporosis). Mulcahy, Nicholas Mar 15, 2003 392
Drug update: prevention of osteoporosis in postmenopausal women. Zoler, Mitchel L.; Brunk, Doug Mar 1, 2003 1487
Raloxifene linked to reduced risk of stroke, TIA. (In High-Risk, Postmenopausal Women). Zoler, Mitchel L. Jan 15, 2003 953
Raloxifene surprises with cardioprotective benefits. (Analysis of Osteoporosis Trial Data). Zoler, Mitchel L. Jan 1, 2003 953
Coronary events fall 40% with Raloxifene therapy: results 'as good as in the statin trials'. (Secondary Analysis of Osteoporosis Trial). Jancin, Bruce Brief Article May 15, 2002 665
Raloxifene appears cardioprotective in high-risk women: the data come from a secondary analysis of a 4-year osteoporosis study. (Preliminary Data). Jancin, Bruce May 15, 2002 587
Does raloxifene affect risk of cardiovascular events in osteoporotic postmenopausal women? (Patient-Oriented Evidence that Matters). Ireland, Belinda Brief Article May 1, 2002 820
Raloxifene subs for tamoxifen in Riedel's thyroiditis. (Clinical Rounds Case Report). Moon, Mary Ann Brief Article Apr 1, 2002 236
When MORE is less. (News you can use). Brief Article Dec 1, 2001 183
Raloxifene May Cut Postmenopausal Depression. Sherman, Carl Aug 1, 2001 265
Raloxifene and Cognition. Brief Article Jul 1, 2001 207
Raloxifene Causes No Increase in CV Events in Women. ZOLER, MITCHEL L. Brief Article May 1, 2001 380
Raloxifene Lowers Risk of Breast Cancer by 72%. JANCIN, BRUCE Brief Article Feb 1, 2001 721
Raloxifene doesn't hike breast density. Brief Article Jan 20, 2001 323
Do Anti-estrogens Protect Against Breast Cancer? Fuchs, Nan Kathryn Brief Article Jan 1, 2001 222
Consider Raloxifene a Safe Alternative to HRT. JOHNSON, KATE Sep 15, 2000 444
Reassuring New Safety Data For Raloxifene. Jancin, Bruce Sep 15, 2000 130
Designer Estrogens. CHRISTENSEN, DAMARIS Oct 16, 1999 2599
Raloxifene hikes bone density in women. Brief Article Sep 4, 1999 199
DOES RALOXIFENE REDUCE BREAST CANCER RISK? Mattimoe, Derek; Newton, Warren Sep 1, 1999 832
Raloxifene imparts anticancer benefit. Seppa, N. Brief Article Jun 19, 1999 450

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters